Cargando…
Altering the mRNA-1273 dosing interval impacts the kinetics, quality, and magnitude of immune responses in mice
For a vaccine to achieve durable immunity and optimal efficacy, many require a multi-dose primary vaccination schedule that acts to first “prime” naive immune systems and then “boost” initial immune responses by repeated immunizations (ie, prime-boost regimens). In the context of the global coronavi...
Autores principales: | Garcia-Dominguez, Dario, Henry, Carole, Ma, LingZhi, Jani, Hardik, Amato, Nicholas J., Manning, Taylor, Freyn, Alec, Davis, Heather, Hsiao, Chiaowen Joyce, Li, Mengying, Koch, Hillary, Elbashir, Sayda, DiPiazza, Anthony, Carfi, Andrea, Edwards, Darin, Bahl, Kapil |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9679967/ https://www.ncbi.nlm.nih.gov/pubmed/36426367 http://dx.doi.org/10.3389/fimmu.2022.948335 |
Ejemplares similares
-
Variant SARS-CoV-2 mRNA vaccines confer broad neutralization as primary or booster series in mice
por: Wu, Kai, et al.
Publicado: (2021) -
Rational Design and In Vivo Characterization of mRNA-Encoded Broadly Neutralizing Antibody Combinations against HIV-1
por: Narayanan, Elisabeth, et al.
Publicado: (2022) -
mRNA-1273 and Ad26.COV2.S vaccines protect against the B.1.621 variant of SARS-CoV-2
por: Darling, Tamarand L., et al.
Publicado: (2022) -
Serum Neutralizing Activity Elicited by mRNA-1273 Vaccine
por: Wu, Kai, et al.
Publicado: (2021) -
Serum Neutralizing Activity of mRNA-1273 against SARS-CoV-2 Variants
por: Choi, Angela, et al.
Publicado: (2021)